Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Cue Biopharma, Inc. | cue-ex321_12.htm |
| EX-31.2 - EX-31.2 - Cue Biopharma, Inc. | cue-ex312_11.htm |
| EX-31.1 - EX-31.1 - Cue Biopharma, Inc. | cue-ex311_10.htm |
| EX-21 - EX-21 - Cue Biopharma, Inc. | cue-ex21_6.htm |
| EX-10.16 - EX-10.16 - Cue Biopharma, Inc. | cue-ex1016_460.htm |
| EX-4.4 - EX-4.4 - Cue Biopharma, Inc. | cue-ex44_461.htm |
| 10-K - 10-K - Cue Biopharma, Inc. | cue-10k_20191231.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (No. 333-229140) on Form S-3 and Registration Statements (Nos. 333-224018 and 333-230282) on Form S-8 of Cue Biopharma, Inc. of our report dated March 11, 2020, relating to the consolidated financial statements of Cue Biopharma, Inc. and Subsidiary, appearing in this Annual Report on Form 10-K of Cue Biopharma, Inc. for the year ended December 31, 2019.
/s/ RSM US LLP
Boston, Massachusetts
March 11, 2020